Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) EBT Growth (3y) (2012 - 2026)

Analysis

Edwards Lifesciences (EW) EBT Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -2.34%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 28.31%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 13.94%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 20.27%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 35.51%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 23.63%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -30.37%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 25.85%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 17.92%
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn -2.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.63%
Mar 31, 2026 4.82%
Dec 31, 2025 -24.66%
Sep 30, 2025 -5.07%
Jun 30, 2025 -4.86%
Mar 31, 2025 -0.17%
Dec 31, 2024 1.21%
Sep 30, 2024 1.00%
Jun 30, 2024 -11.04%
Mar 31, 2024 -1.57%
Dec 31, 2023 1.03%
Sep 30, 2023 2.09%
Jun 30, 2023 53.76%
Mar 31, 2023 3.03%
Dec 31, 2022 -12.49%
Sep 30, 2022 10.52%
Jun 30, 2022 19.65%
Mar 31, 2022 16.19%
Dec 31, 2021 495.39%
Sep 30, 2021 16.27%